#BiotechHangout is taking a break this week and will return on Friday, October 16, at 12pm ET. Until next week, stream the latest episodes on Spotify, Apple Podcasts, Amazon Music, YouTube, and biotechhangout.com.

#BiotechHangout Graig Suvannavejh, Sam Fazeli, Eric Schmidt & Brian Skorney on biotech market review & IPOs, $MRNA on Nasdaq 100, deals: $AZN/$SMMT, AZN-Daiichi-$SMMT, $NVO/Hengrui, $REGN/$SNY, company news: $MIRM, $ABBV, $MRK, data: $DYN, $MIRM, $KOD, $IMMX, $QURE, #EASD, #WCLC, #AAO bit.ly/3TFmfQK

#BiotechHangout: Sam Fazeli, Brian Skorney, Matt Gline, Yaron Werber on market & policy: MFN & revenue sharing, IPOs ($ETRA), Heidi Overton's FDA confirmation hearing, $CMPX, stock moves: $OMER, $CGEM, $MAZE, data: $VRTX, $CLDX, $VKTX, $AMGN, $IONS, $MRNA, $ROIV, $LXEO, Roche: bit.ly/3TjKnby

#BiotechHangout: Eric Schmidt, Josh Schimmer, Paul Matteis, Adam Feuerstein on markets: sloppy Sept., $SION in CF, AI in biotech, reverse mergers vs IPOs, rare disease ($SRRK, $RCKT, $RARE) policy: measles outbreak oncology innovation & ivonescimab news, plus $XENE, $DFTX, $CNTM: bit.ly/4xBJg54

#BiotechHangout is taking a break this week in recognition of Labor Day and will return on Friday, September 11, at 12pm ET. Until next week, stream the latest episodes on Spotify, Apple Podcasts, Amazon Music, YouTube, and biotechhangout.com. Have a wonderful holiday weekend!